Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases,
and it is one of the leading causes of cancer death in both men and women worldwide due …

RNA interference (RNAi) has been thought of as the general answer to many unmet medical
needs. After the first success stories, it soon became obvious that short interfering RNA …

Lung cancer is a malignancy with a high morbidity and mortality rate, and affected patients
have low survival and poor prognosis. The therapeutic approaches for the treatment of this …

Nanomaterials can enhance the delivery and treatment efficiency of anti-cancer drugs, and
the mechanisms of the tumorreducing activity of nanomaterials with cancer drug have been …

Background and ethnopharmacological relevance: Matrine (MT), a type of alkaloid extracted
from the Sophora family of traditional Chinese medicine, has been documented to exert a …

Lung cancer is a complex disease caused by a multitude of genetic and environmental
factors. The progression of lung cancer involves dynamic changes in the genome and a …

Resistance to cisplatin-based chemotherapy is a major cause of treatment failure in
advanced bladder cancer (BC) patients. There is increasing evidence that microRNAs are …

RNA interference (RNAi) has emerged as a powerful tool for studying target identification
and holds promise for the development of therapeutic gene silencing. Recent advances in …

Among cancers, lung cancer is the most morbidity and mortality disease that is remaining
the fatalist. Generally, there are multiple treatment procedures for lung cancer, such as …

Lung adenocarcinoma (LUAD) is the most predominant subtype of non‑small cell lung
cancer (NSCLC) that is experiencing the fastest growth rate in incidence. Chemoresistance …